Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.
about
Ghrelin.Therapeutic Potential of Targeting the Ghrelin Pathway.Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.Novel therapeutic agents in neurogastroenterology: advances in the past year.Drug-drug interactions in pharmacologic management of gastroparesis.Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner.Peripheral mechanisms in appetite regulation.Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin ReceptorContrasting Perspectives of Anesthesiologists and Gastroenterologists on the Optimal Time Interval between Bowel Preparation and Endoscopic Sedation.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Gastric Dysmotility in Critically Ill Children: Pathophysiology, Diagnosis, and Management.Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitusFuture Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.Diabetic gastroparesis: recent insights into pathophysiology and implications for management.Gastroparesis: from concepts to management.Ghrelin signaling in the gut, its physiological properties, and therapeutic potential.A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.Delayed gastric emptying in Parkinson's disease.Phase II drugs under clinical investigation for the treatment of chronic constipation.Gastric emptying and glycaemia in health and diabetes mellitus.Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.Current and Emerging Medical Therapies for Gastroparesis.Gastroparesis: Medical and Therapeutic Advances.Novel Diet, Drugs, and Gastric Interventions for Gastroparesis.Pathological Findings of the Antral and Pyloric Smooth Muscle in Patients with Gastroparesis-Like Syndrome Compared to Gastroparesis: Similarities and Differences.Safety of treatment for gastroparesis.Newest Drugs for Chronic Unexplained Nausea and Vomiting.Relamorelin for the treatment of gastrointestinal motility disorders.Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers.Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.Diabetes and the Small Intestine.Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?Diabetic gastroparesis: current challenges and future prospects
P2860
Q28081062-9C328EF2-3F15-445B-83AE-5C06BB2187A7Q33624632-69758F28-E065-470A-AC4D-BECB5F775096Q33887129-7D71DB1C-68B0-4E11-8846-550AA99CF256Q33934623-1B2BEA68-0F76-47C1-BE74-16FEC54FECAAQ34480053-05ED09FF-213B-468B-9217-2C4209553569Q35201327-9A56A881-ACED-42A3-9AA0-D31B4CC53D4FQ35204654-0BA949A2-4987-4C11-8296-8EC5B362E109Q35584740-0D8B5396-AA20-4973-AD41-01A0DA6A7A01Q35596484-E2D918F9-50A7-48F2-97B1-BE13789616E1Q35807597-0709FFBC-BA4F-4259-9EDD-96A451BADBB6Q36082843-7F9AB027-7B51-4867-BCF3-BAA59F516EB3Q36253697-B3E1DEEF-D4A7-4ACD-B93C-B88BAAD9A2A2Q37200907-FA24F8CC-D059-45F4-902E-60E9E1C288E9Q37248624-590DC5C0-E8E7-4D62-9F22-5DB326BFA356Q37740008-BF63AFBA-57A7-48D0-AA3D-531A1812180BQ38077822-D2C37C95-D9B2-4660-9840-A814D3E6E1B1Q38116759-D50A228A-45C9-4B16-B3E6-F4D23537FE5EQ38126139-5C897A76-5900-4B78-8CA2-461F8293B07AQ38133838-4367545E-D5FB-4CA6-BB08-BBCA6DD16A04Q38154857-96B04C17-F422-406D-8D83-AEDAF2F17B18Q38222819-30C35E87-2D59-4D19-A6C2-922572890F35Q38271037-E5AB3BC8-6A24-492A-B771-EBA0A05121A3Q38363587-619B2D86-CDCA-4758-A169-3BA2DD68E650Q38587559-1D46F59E-0250-4F31-9C98-B6BB6380941CQ38617535-63859485-A856-4CD2-9431-8D3DD3F6A20AQ38672906-49486404-0173-468B-81B8-8F8FB6926CDEQ38695314-42468B23-E2A5-4757-BA1C-30733E2B2C0DQ38747257-CB27CFF3-85BE-4B13-8B09-7263B143BF71Q38794290-484B8FD2-71F1-428D-AC87-0E56129DF308Q38977503-FE1FF4D8-0223-42A9-BFD9-3F9FD7586999Q39150802-DEF32B1C-6C7E-4FFD-B58D-5CDCE4C728A9Q42721572-5D40F71F-640E-4E3C-82EE-0F7867FCB868Q47816254-B77BA356-6F4B-41E0-A573-0E1F951370CCQ50075045-847EF6F2-5346-4F25-8596-D3F8CE882FABQ51295486-29AF1D96-0278-4294-A6C3-A7FA550305FCQ55555487-EC09648C-1036-4DA2-BD60-90422819D4E9Q57491893-D1A1A6CD-C8C7-4049-ABB3-4D651FD6A7EC
P2860
Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@ast
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@en
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@nl
type
label
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@ast
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@en
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@nl
prefLabel
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@ast
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@en
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@nl
P2093
P2860
P356
P1433
P1476
Randomized controlled phase Ib ...... kinetics and pharmacodynamics.
@en
P2093
Adrian Vella
Andrea Shin
Duane Burton
Elizabeth Stoner
Irene Busciglio
Keith Gottesdiener
Patrick Noonan
Steven A Smith
P2860
P356
10.2337/DC12-1128
P407
P577
2012-09-06T00:00:00Z